4.6 Article

Multidrug resistance phenotype and its relation to stem cell characteristics in chronic myeloid leukemia

期刊

GENE
卷 892, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.gene.2023.147848

关键词

ALOX5 gene; Cancer stem cells; Daunorubicin chemotherapeutic; K562 cell line; OCT4

向作者/读者索取更多资源

The present study aimed to evaluate the expression profile of genes related to stem cells characteristics during the acquisition of multidrug resistance phenotype in chronic myeloid leukemia. The results showed a direct relationship between the expression of ABCB1 and OCT4 genes in drug-resistant cells, and an inverse relationship between the expression of ALOX5 and ABCB1 genes.
The present work aimed to evaluate the expression profile of genes related to stem cells (SC) characteristics during the acquisition of the multidrug resistance (MDR) phenotype in the chronic myeloid leukemia (CML). For this, the K562 (non MDR) and FEPS (MDR) cell lines were used. K562 cells had resistance induced by exposure to daunorubicin (DNR), and induction was confirmed by flow cytometry with an increase in ABCB1 expression in K562 cells treated at the highest concentration. Real-time PCR gene expression analysis showed a direct relationship in the expression of OCT4 and ABCB1 genes, with an increase in ABCB1 expression after exposure to DNR, followed by an increase in OCT4 gene expression. This direct relationship was confirmed in the MDR FEPS cells that had the ABCB1 gene silenced. For the ALOX5 gene, we observed an inverse relationship with ABCB1, with a decrease in the expression of ALOX5 in the DNR-transformed K562 cells, and an increase in the expression of this gene when ABCB1 was silenced in the FEPS cells. Thus, during the acquisition of the MDR phenotype by the K562 cells, it was possible to observe that there is an increase in the expression of ABCB1, accompanied by the expression of OCT4, while the expression of ALOX5 is decreased.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据